(C6), 47.81 (C5), 48.48 (C13), 64.29 (C15), 65.65 (C12), 66.28
prepared from epiisororidin E (2). The obtained sample was 2-
naphthoylated under the conditions similar to those mentioned
above by employing 2-naphthoyl chloride (2.0 mg), DMAP (2.0
mg), and CH2Cl2 (0.5 mL). Then, a workup similar to that
discussed above and the following preparative silica gel TLC
under the same conditions afforded the bis(2-naphthoate) 4 (0.6
mg, the quantity was estimated by assuming its ε value at 236 nm
to be 135000). ECD (7.0 × 10−6 mol/L, CH3CN) ∆ε242 +6.8, ∆ε229
−20.2. The chromatographic property and the ECD profile of this
sample were identical to those derived from 2.
ACCEPTED MANUSCRIPT
(C5′), 67.06 (C11), 68.48 (C13′), 75.06 (C4), 79.24 (C2), 81.83
(C6'), 117.24 (C2′), 118.82 (C10), 119.06 (C10′), 131.05 (C8′),
134.68 (C7′), 140.26 (C9), 142.33 (C9′), 157.99 (C3′), 166.35
(C1′), 166.42 (C11′), ESIMS (rel. int. %) m/z 537.2460 (45,
calcd. for C29H38ONa [M+Na]+: 537.2464), 532.2905 (100, calcd.
for C29H42NO8 [M+NH4]+: 529.2910), 515.2640 (27, calcd. for
1
C29H39O8 [M+H]+: 515.2645). The H and 13C NMR data of this
sample were coincident with those reported by Jarvis.16
Verrucarol (4,15)-O-bis(2-naphthoate) 4 from epiisororidin E (2)
Modeling calculations
Epiisororidin E (2, 10 mg) was stirred with K2CO3 (20 mg) in
MeOH (1.0 mL) at room temperature for 2 h. The suspension
was diluted with diethyl ether (5.0 mL) and then filtered. The
filtrate was concentrated in vacuum and then subjected to
preparative silica gel TLC. Development with EtOAc:hexane
(80:20) afforded 3 (4.5 mg; Rf = 0.2 under the above conditions).
Eight isomeric models, namely ERR, ESR, ERS, ESS, ZRR,
ZSR, ZRS, and ZSS, were constructed using Spartan’14. The
three letters for the models refer to the configurations at the 2′, 4′,
and 5′ positions, respectively. A conformational search for each
model was performed using MMFF by setting the rotation at
C15-O bonding, and the flips at C1′, C2′, C3′, C4′, C5′, C7′, C8′,
C9′, C10′, and C11′, which theoretically generate 354294 initial
conformers and the search gave 100 candidates of stable
conformers in each model. In some models, the program
automatically judged the completion of the search to terminate
after checking approximately 1 × 104 conformers. The candidates
were refined with HF/STO-3G. After removing the overlaps,
conformers (4–9 conformers) within 10 kJ/mol from the global
minimum conformer were further optimized stepwise by
EDF2/6-31G* and ωB97X-D/6-31G* on Spartan’14 and
Spartan’16, respectively, considering the entropy term using a
vibrational analysis (the software was updated during the
research period). The optimized conformers were subjected to
chemical shift calculations with the ωB97X-D/6-31G*.
Distributions of the conformers were estimated based on the
relative free energies (∆G) and the Boltzmann distribution law.
Theoretical chemical shifts were corrected based on the
distributions of the conformers. Major conformers existing in
cumulatively 90 % populations of models ERR, ESR, ERS, and
ESS were subjected to ECD calculations on Turbomole X
(version 7.1) with def2-TZVP/BH-LYP//ωB97X-D/6-31G*. Fifty
excitations were examined to express the UV and ECD spectra in
the range 200–600 nm. The UV and ECD spectra of each
conformer were constructed based on the frequencies as well as
the oscillator strength and the rotary strength, respectively, by
employing the NORMDIST function in Microsoft Excel® 2016
(standard deviation = 14 nm for UV spectra; 15 nm for ECD
spectra). The wavelengths for these spectra were corrected (+14
nm) based on the experimental UV absorption of 1. Theoretical
UV and ECD spectra were obtained after correction based on the
conformational distributions. The theoretical UV intensity of
model ERR was normalized with experimental data at 260 nm,
and the same parameter was used for the other models. The
intensities of the theoretical ECD spectra were appropriately
adjusted.
22
21
[α]D = −31.5° (c 0.41 CHCl3), (lit: [α]D −40.6 (c 0.13,
CHCl3).19 1H NMR (500 MHz, CDCl3) δ 0.95 (3H, s, H3-14),
1.36 (1H, br, alcoholic proton at C15O), 1.66 (1H, brd. J = 9.1
Hz, alcoholic proton at C4O), 1.72 (3H, s, H3-16), 1.74 (1H, dt, J
= 1.8, 5.5 Hz, H-7), 1.91 (1H, ddd, J = 3.0, 5.5, 15.5 Hz, Hβ-3),
1.96 (1H, dd, J = 6.0, 12.3 Hz, H-7), 2.05 (2H, m, H-8), 2.58
(1H, dd, J = 7.5, 15.5 Hz, Hα-3), 2.81, 3.11 (each 1H, d, J = 3.9
Hz, H2-13), 3.57, 3.76 (each 1H, d, J = 11.7 Hz, H2-15), 3.62
(1H, d, J = 5.4 Hz, H-11), 3.82 (1H, d, J = 5.5 Hz, H-2), 4.63
(1H, br, H-4), 5.43 (1H, d, J = 5.4 Hz, H-10), 13C NMR (125
MHz, CDCl3) δ 7.29 (C14), 20.99 (C7), 23.28 (C16), 28.25 (C8),
39.96 (C3), 43.89 (C6), 47.64 (C13), 49.00 (C5), 62.55 (C15),
65.71 (C12), 66.54 (C11), 74.56 (C4), 78.67 (C2), 118.77 (C10),
141.05 (C9), ESIMS (rel. int. %) m/z 289.1408 (66, calcd. for
C15H22O4Na [M+Na]+: 289.1416), 267.1585 (60, calcd. for
C15H23O4 [M+H]+: 267.1596), and 249.1485 (100, calcd. for
C15H21O3 [MH-H2O]+: 249.1491). The 1H and 13C data were
coincident with those in the literature.19
Verrucarrol (3) (1.0 mg) thus prepared was stirred with 2-
naphthoyl chloride (5.0 mg) and N,N-dimethyl-4-aminopyridine
(DMAP, 4.0 mg) in CH2Cl2 (0.2 mL) at room temperature for 30
min. Diethyl ether (5.0 mL) was added to the mixture, and the
resulting suspension was filtered through a cotton filter. After
concentration in vacuo, the residue was purified using silica gel
column chromatography (EtOAc:hexane = 33:67) to give the
bis(2-naphthoate) 4 (1.6 mg, Rf = 0.45 under the above
conditions, and the quantity of the sample was estimated by
assuming its ε value at 236 nm to be 135000). ECD (7.0 × 10−6
1
mol/L, CH3CN) ∆ε242 +6.8, ∆ε229 −20.2, H NMR (500 MHz,
CDCl3) δ 1.13 (3H, s, H3-14), 1.75 (3H, s, H3-16), 1.98–2.12 (3H,
m, H-7, H-8), 2.18 (1H, dd, J = 6.0, 11.6 Hz, H-7), 2.26 (1H,
ddd, J = 3.5, 5.3, 15.5 Hz, Hβ-3), 2.77 (1H, dd, J = 7.5, 15.5 Hz,
Hα-3), 3.00, 3.26 (each 1H, d, J = 4.1 Hz, H2-13), 3.91 (1H, d, J
= 5.4 Hz, H-11), 3.97 (1H, d, J = 5.3 Hz, H-2), 4.42, 4.64 (each
1H, d, J = 12.3 Hz, H2-15), 5.53 (1H, dd, J = 1.5, 5.4 Hz, H-10),
6.05 (1H, dd, 3.5, 7.5 Hz, H-4), 7.50–7.60 (4H, aromatic
protons), 7.83–7.88 (4H, aromatic protons), 7.94, 7.97 (each 1H ,
brd, J = 8.0 Hz, aromatic protons), 8.01, 8.06 (each 1H, dd, J =
1.4, 8.4 Hz, aromatic protons), 8.58, 8.60 (each 1H, brs,
aromatic protons). ESIMS (rel. int. %) m/z 597.2245 (33, calcd.
for C37H34O6Na [M+Na]+: 597.2253), 592.2683 (54, calcd. for
C37H38NO6 [M+NH4]+: 592.2699), and 575.2421 (100, calcd. for
C37H35O6 [M+H]+: 575.2434).
X-ray diffraction analysis25
A solution of 1 (approximately 10 mg) in a mixture of 1:1
EtOAc and hexane (0.3 mL) was stood at room temperature for a
week to precipitate the crystalline. After the mother liquid was
pipetted off, diethyl ether (0.2 mL) was added and the mixture
was gently agitated for 10 second at room temperature. The
ethereal liquid was quickly removed by pipetting to give the
yellowish single crystals. Data were collected at 123 K on a
Rigaku RAXIS RAPID II imaging plate diffractometer using
graphite-monochromated Mo Ka radiation (λ = 0.71075 Å) and
corrected by the Lorentz, polarization, and absorption effects.
The structure was solved by direct methods (SHELXS-97) and
refined on F2 using the full-matrix least-squares method
Preparation of 4 from roridin J (1)
In the same manner as above, roridin J (1, 1.5 mg) was treated
with K2CO3 (10 mg) in MeOH (0.5 mL). The similar workup and
purification gave 3 (approximately 1.5 mg). The 1H NMR
spectrum of the crude sample agreed with that of the sample
6